Marek J. Bozdech

496 total citations
18 papers, 390 citations indexed

About

Marek J. Bozdech is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Marek J. Bozdech has authored 18 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Marek J. Bozdech's work include Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marek J. Bozdech is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marek J. Bozdech collaborates with scholars based in United States. Marek J. Bozdech's co-authors include C B Begg, PA Cassileth, J M Bennett, C Weiler, Philip Rubin, Colin B. Begg, Robert Silber, John M. Bennett, Michael E. Trigg and Enid F. Gilbert and has published in prestigious journals such as Blood, Annals of Internal Medicine and PEDIATRICS.

In The Last Decade

Marek J. Bozdech

18 papers receiving 372 citations

Peers

Countries citing papers authored by Marek J. Bozdech

Since Specialization

Citations

This map shows the geographic impact of Marek J. Bozdech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek J. Bozdech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek J. Bozdech more than expected).

Fields of papers citing papers by Marek J. Bozdech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek J. Bozdech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek J. Bozdech. The network helps show where Marek J. Bozdech may publish in the future.

Co-authorship network of co-authors of Marek J. Bozdech

This figure shows the co-authorship network connecting the top 25 collaborators of Marek J. Bozdech. A scholar is included among the top collaborators of Marek J. Bozdech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek J. Bozdech. Marek J. Bozdech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm study 2006 ·British Journal of Haematology ·James R. Berenson, Ralph V. Boccia, David S. Siegel, Marek J. Bozdech, Alberto Bessudo, Edward A. Stadtmauer, (unknown), Ronald G. Steis, Marshall S. Flam, Jose Lutzky, (unknown), (unknown), Siu‐Fun Wong, Robert A. Moss, Ravi Patel, (unknown), (unknown), (unknown), Howard Yeh, Regina A. Swift	64
2	A Multicenter Phase II Study of Combination Treatment with Melphalan, Arsenic Trioxide and Vitamin C (MAC) for Patients with Relapsed or Refractory Multiple Myeloma. 2005 ·Blood ·James R. Berenson, Ralph V. Boccia, David S. Siegel, Marek J. Bozdech, Alberto Bessudo, Edward A. Stadtmauer, (unknown), Ronald G. Steis, Marshall S. Flam, Jose Lutzky, (unknown), (unknown), (unknown), Robert A. Moss, Ravi Patel, (unknown), Howard Yeh, (unknown)	4
3	Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome 1988 ·American Journal of Hematology ·Dominik Stoll, Powers Peterson, (unknown), John László, Anthony V. Pisciotta, John Ellis, Patrick B. White, (unknown), Marek J. Bozdech, S Murphy	52
4	B Cell Lymphoproliferative Disorders Following T Cell Depleted Allogeneic Bone Marrow Transplantation 1988 ·Journal of Pediatric Hematology/Oncology ·(unknown), Enid F. Gilbert, Richard Hong, Marek J. Bozdech, Bridget Flynn, Wayne Borcherding, Gholam R. Hafez, Sunita Arya, Michael E. Trigg, Jonathan L. Finlay, Paul M. Sondel	18
5	Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation 1987 ·Cancer ·Michael E. Trigg, (unknown), Marek J. Bozdech, Enid F. Gilbert	19
6	Cytomegalovirus-Associated Tubulointerstitial Nephritis in an Allogeneic Bone Marrow Transplant Recipient 1987 ·Annals of Internal Medicine ·Ronald I. Shorr, Walter Longo, Terry D. Oberley, Marek J. Bozdech, Duard L. Walker	12
7	In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease. 1986 ·PubMed ·Peter Köhler, (unknown), (unknown), Michael E. Trigg, Bruce S. Edwards, Richard Hong, Jacquelyn A. Hank, Ronald Billing, Marek J. Bozdech, Paul M. Sondel	1
8	Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk. 1986 ·PubMed ·ME Trigg, Alan C. Peterson, (unknown), Marek J. Bozdech, Ronald Billing, Paul M. Sondel, (unknown), Jean E. Surfus, (unknown), Robert Hong	16
9	A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia 1984 ·Blood ·PA Cassileth, C B Begg, J M Bennett, Marek J. Bozdech, (unknown), C Weiler, (unknown)	118
10	Late recurrences of histiocytic lymphoma after treatment 1984 ·Cancer ·H. Ian Robins, Richard A. Steeves, Thomas E. Davis, Marek J. Bozdech, James P. AuBuchon, Gholam‐Reza Hafez	9
11	Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement. 1984 ·PubMed ·(unknown), Ronald Billing, Sondel Pm, (unknown), (unknown), (unknown), Marek J. Bozdech, Ruey‐Long Hong, Hesed Padilla‐Nash, Paul I. Terasaki	13
12	The in vivo distribution of indium-111 labeled in vitro alloactivated syngeneic lymphocytes in a patient with relapsed acute myelomonocytic leukemia: Implications for adoptive chemoimmunotherapy 1984 ·Leukemia Research ·Paul M. Sondel, Peter Köhler, Jacquelyn A. Hank, Marek J. Bozdech, Lionel M. Lieberman, Richard Hong, Richard J. Albertini, (unknown)	3
13	Pediatric Bone Marrow Transplantation: Current Progress and Future Prospects 1983 ·PEDIATRICS ·Paul M. Sondel, Michael E. Trigg, Richard Hong, Jonathan L. Finlay, Marek J. Bozdech	2
14	Management of Fulminating Thrombotic Thrombocytopenic Purpura 1981 ·Seminars in Thrombosis and Hemostasis ·Stuart J. Updike, Marek J. Bozdech, Curtis L. Johnson, (unknown)	4
15	The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ecog study Part : Total body irradiation—Response and toxicity 1981 ·International Journal of Radiation OncologyBiologyPhysics ·Philip Rubin, John M. Bennett, Colin B. Begg, Marek J. Bozdech, Robert Silber	37
16	Partial Peroxidase Deficiency in Neutrophils and Eosinophils Associated with Neurologic Dise: Histochemical, Cytochemical and Biochemical Studies 1980 ·American Journal of Clinical Pathology ·Marek J. Bozdech, D F Bainton, Piero Mustacchi	15
17	Aspirin therapy in microangiopathic hemolytic anemia and renal failure 1977 ·The American Journal of the Medical Sciences ·Peter C. Raich, Marek J. Bozdech	2
18	Advances in the treatment of carcinoma of the breast. 1976 ·PubMed ·(unknown), Marek J. Bozdech	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact